Oruka Therapeutics (ORKA) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 53.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.55% |
| Dec 31, 2025 | -209.60% |
| Sep 30, 2025 | 131.16% |
| Jun 30, 2025 | -91.00% |
| Mar 31, 2025 | 92.34% |
| Dec 31, 2024 | -313.12% |
| Sep 30, 2024 | 336.26% |
| Jun 30, 2024 | -50.05% |
| Mar 31, 2024 | 15.81% |
| Dec 31, 2023 | 19.50% |
| Sep 30, 2023 | -26.86% |
| Jun 30, 2023 | 12.75% |
| Mar 31, 2023 | 1.89% |
| Dec 31, 2022 | -5.23% |
| Sep 30, 2022 | -98.58% |
| Jun 30, 2022 | -49.45% |
| Mar 31, 2022 | -71.86% |
| Dec 31, 2021 | -50.68% |
| Sep 30, 2021 | -45.70% |
| Jun 30, 2021 | -14.93% |
| Mar 31, 2021 | 73.94% |
| Dec 31, 2020 | -77.73% |
| Sep 30, 2020 | 252.41% |
| Jun 30, 2020 | -33.07% |
| Mar 31, 2020 | -11.12% |
| Dec 31, 2019 | -22.70% |
| Sep 30, 2019 | 62.97% |
| Jun 30, 2019 | 28.62% |
| Mar 31, 2019 | 29.14% |
| Dec 31, 2018 | 18.55% |
| Sep 30, 2018 | 15.36% |
| Jun 30, 2018 | -27.59% |
| Mar 31, 2018 | 45.35% |
| Dec 31, 2017 | 31.91% |
| Sep 30, 2017 | 23.33% |
| Jun 30, 2017 | 53.41% |
| Mar 31, 2017 | -31.56% |
| Dec 31, 2016 | 28.21% |
| Sep 30, 2016 | -53.37% |
| Jun 30, 2016 | -42.78% |
| Mar 31, 2016 | -155.73% |
| Dec 31, 2015 | -154.80% |
| Sep 30, 2015 | -195.42% |
| Jun 30, 2015 | 219.31% |
| Mar 31, 2015 | -22.70% |
| Dec 31, 2014 | -127.13% |
| Sep 30, 2014 | -7.46% |
| Jun 30, 2014 | 4.76% |
| Mar 31, 2014 | 62.51% |
| Dec 31, 2013 | -28.65% |
| Sep 30, 2013 | 4.67% |